Latest filing published 16 Sept 2015 for SYNERGY PHARMACEUTICALS, INC., €30k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Bernard Denoyer: trading record in brief
This profile gathers the share dealings of Bernard Denoyer across 2 companies, led by Synergy Pharmaceuticals, Inc. and Hepion Pharmaceuticals, Inc. In total, 5 filings cover trades dated from 21 June 2013 to 14 September 2015.
In open-market terms, that means 2 purchases worth €34k on one side and 1 sale worth €66k on the other. On balance, insiders were net sellers of €32k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 option exercise. Since January 2015: no purchases and 1 sale on the market.
The record was last updated on 16 September 2015 with an option exercise (€30k) in Synergy Pharmaceuticals, Inc. The most recent open-market purchase was published on 28 May 2014, 4,547 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Bernard Denoyer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$3.40Common StockSEC:0001104659-15-065544:0
- 10,000 shares@ US$7.50Common StockSEC:0001104659-15-065544:1
- 2,500 shares@ US$3.89Common StockSEC:0001104659-14-041835:0Canonical exit: 21 Aug 2014 (T+90)
- 1,030 sharesCommon Stock, par value $0.0001 per shareSEC:0001104659-14-011939:0
- 7,500 shares@ US$4.78Common StockSEC:0001104659-13-050885:0Canonical exit: 19 Sept 2013 (T+90)
5 of 5 declarations